PMID- 19543218 OWN - NLM STAT- MEDLINE DCOM- 20100126 LR - 20240109 IS - 1930-7381 (Print) IS - 1930-7381 (Linking) VI - 17 IP - 10 DP - 2009 Oct TI - Central administration of an endoplasmic reticulum stress inducer inhibits the anorexigenic effects of leptin and insulin. PG - 1861-5 LID - 10.1038/oby.2009.194 [doi] AB - Leptin and insulin are important anorexigenic hormones acting on the hypothalamus. However, most obese humans and animals have reduced hypothalamic responses to leptin and insulin. Increased endoplasmic reticulum (ER) stress has been shown to cause insulin resistance in the livers of obese animals. In the present study, we investigated a role of ER stress in the development of central leptin and insulin resistance. Intracerebroventricular (ICV) administration of the ER stress inducer thapsigargin (TG) increased food intake and body weight. Furthermore, ICV or intra-hypothalamic administration of TG inhibited the anorexigenic and weight-reducing effects of leptin and insulin. ICV administration of TG by itself activated signal-transduction-activated-transcript-3 (STAT3) and Akt in the hypothalamus, but prevented a further activation of hypothalamic STAT3 and Akt by leptin and insulin. We also found that the expression of the ER stress markers such as phosphorylation of the inositol-requiring kinase-1 (IRE1), spliced form of X-box-binding protein-1 (XBP-1s), glucose-regulated/binding immunoglobulin protein-78, and C/EBP homology protein (CHOP) increased in the hypothalami of diet-induced obese (DIO) mice. Furthermore, treatment of chemical chaperone 4-phenyl butylic acid significantly improved central leptin resistance in DIO mice. These findings suggest that increased hypothalamic ER stress in obese animals may induce central leptin and insulin resistance. FAU - Won, Jong Chul AU - Won JC AD - Department of Internal Medicine, Mitochondrial Research Group, Inje University College of Medicine, Seoul, Korea. FAU - Jang, Pil-Geum AU - Jang PG FAU - Namkoong, Churl AU - Namkoong C FAU - Koh, Eun Hee AU - Koh EH FAU - Kim, Suk Kyeoug AU - Kim SK FAU - Park, Joong-Yeol AU - Park JY FAU - Lee, Ki-Up AU - Lee KU FAU - Kim, Min-Seon AU - Kim MS LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090618 PL - United States TA - Obesity (Silver Spring) JT - Obesity (Silver Spring, Md.) JID - 101264860 RN - 0 (DNA-Binding Proteins) RN - 0 (Enzyme Inhibitors) RN - 0 (Insulin) RN - 0 (Leptin) RN - 0 (Regulatory Factor X Transcription Factors) RN - 0 (STAT3 Transcription Factor) RN - 0 (Stat3 protein, mouse) RN - 0 (Transcription Factors) RN - 0 (X-Box Binding Protein 1) RN - 0 (XBP1 protein, human) RN - 0 (Xbp1 protein, mouse) RN - 147336-12-7 (Transcription Factor CHOP) RN - 63231-63-0 (RNA) RN - 67526-95-8 (Thapsigargin) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) SB - IM MH - Animals MH - Blotting, Western MH - DNA-Binding Proteins/physiology MH - Endoplasmic Reticulum/*drug effects/physiology MH - Enzyme Inhibitors/*administration & dosage MH - Hypothalamus/*drug effects/physiopathology MH - Insulin/*physiology MH - Leptin/antagonists & inhibitors/*physiology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Obesity/drug therapy/*physiopathology MH - Phosphatidylinositol 3-Kinases/physiology MH - RNA/chemistry/genetics MH - Regulatory Factor X Transcription Factors MH - Reverse Transcriptase Polymerase Chain Reaction MH - STAT3 Transcription Factor/physiology MH - Thapsigargin/*administration & dosage MH - Transcription Factor CHOP/genetics/physiology MH - Transcription Factors/physiology MH - X-Box Binding Protein 1 EDAT- 2009/06/23 09:00 MHDA- 2010/01/27 06:00 CRDT- 2009/06/23 09:00 PHST- 2009/06/23 09:00 [entrez] PHST- 2009/06/23 09:00 [pubmed] PHST- 2010/01/27 06:00 [medline] AID - oby2009194 [pii] AID - 10.1038/oby.2009.194 [doi] PST - ppublish SO - Obesity (Silver Spring). 2009 Oct;17(10):1861-5. doi: 10.1038/oby.2009.194. Epub 2009 Jun 18.